Pro-apoptotic therapy with the oligonucleotide Genasense (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab (Q40487647)
Jump to navigation
Jump to search
scientific article published in December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pro-apoptotic therapy with the oligonucleotide Genasense (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab |
scientific article published in December 2004 |
Statements
1 reference
Pro-apoptotic therapy with the oligonucleotide Genasense (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab (English)
1 reference
Jeyanthi Ramanarayanan
1 reference
Francisco J Hernandez-Ilizaliturri
1 reference
Asher Chanan-Khan
1 reference
Myron S Czuczman
1 reference
1 December 2004
1 reference
1 reference
127
1 reference
5
1 reference
519-530
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference